Ironwood Pharma (IRWD) Misses Q2 EPS by 1c

Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $54.4 million versus the consensus estimate of $55.46 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)